American Journal of Analytical Chemistry

Volume 6, Issue 10 (September 2015)

ISSN Print: 2156-8251   ISSN Online: 2156-8278

Google-based Impact Factor: 1.71  Citations  h5-index & Ranking

Stability Indicating RP-UPLC Method for Assay of Emtricitabine and Tenofovir Disoproxil Fumarate in Bulk and Dosage Forms

HTML  XML Download Download as PDF (Size: 1785KB)  PP. 807-821  
DOI: 10.4236/ajac.2015.610077    3,405 Downloads   5,784 Views  Citations

ABSTRACT

A simple, sensitive and rapid stability indicating reverse phase ultra performance liquid chromatography (RP-UPLC) method was developed and validated for the determination of Emtricitabine (EMT) and Tenofovir disoproxil fumarate (TDF) in pure and tablet dosage forms. The chromatographic separation was achieved by using Waters (Alliance) UPLC system equipped with auto-sampler and photo diode array detector. A volume of 5 μL of standard or test was injected into the column and the components were separated by using the mixture of 0.68% potassium dihydrogen orthophosphate buffer of pH = 6 and methanol in the ratio 45:55 v/v as mobile phase at a flow rate of 1.2 mL/min through BEH C18 (100 mm × 2.1, 1.8 μm) at ambient temperature and were detected at a wavelength of 261 nm. System suitable parameters such as plate count and tailing factor for EMT and TDF were found to be 2427 & 3685, 1.16 & 1.23 respectively, and resolution between EMT and TDF peaks was found to be 3.12. The chromatographic parameters like retention time, peak area and peak height of EMT and TDF were found to be 0.684 & 0.930, 694,200 & 8,778,000 and 272,881 & 3685 respectively. Percent of assay of EMT and TDF in bulk and dosage forms was determined and found to be 101.48 and 103.22 respectively. Study of degradation was examined and found that the drugs were stable under degradation conditions. The present method was developed keeping the principles of green chemistry by using eco-friendly solvent methanol in mobile phase. The developed method was found to be simple, rapid and applied for the analysis of Truvada; therefore the proposed method is recommended for the analysis of EMT and TDF in pure and tablet dosage forms in any quality control laboratories.

Share and Cite:

Purnima, B. , Reddy, T. , Rao, Y. , Ramu, G. and Ramachandran, D. (2015) Stability Indicating RP-UPLC Method for Assay of Emtricitabine and Tenofovir Disoproxil Fumarate in Bulk and Dosage Forms. American Journal of Analytical Chemistry, 6, 807-821. doi: 10.4236/ajac.2015.610077.

Cited by

[1] Simultaneous determination of emtricitabine, tenofovir alafenamide fumarate and dolutegravir sodium by validated stability-indicating RP-HPLC-DAD method
Annales Pharmaceutiques Françaises, 2022
[2] Method Development and Validation for Estimation of Tinofovir Disoproxil Fumarate in Pharmaceutical Preparation by UV-Spectroscopy and HPLC with Force …
2021
[3] p-Sulfonatocalixarene versus p-thiasulfonatocalixarene: encapsulation of tenofovir disoproxil fumarate and implications to ESI-MS, HPLC, NMR, DFT and anti-MRSA …
2021
[4] Quantitative Analysis of Emtricitabine in Dosage Forms Using Green RP-HPTLC and Routine NP-HPTLC Methods—A Contrast of Validation Parameters
2020
[5] A REVIEW ON VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE IN A …
2020
[6] A REVIEW OF ANALYTICAL TECHNIQUES FOR DETERMINATION OF ANTI-HIV DRUGS
2020
[7] Method Development and Validation for Simultaneous Estimation of Emtricitabine, Tenofovir Disoproxil Fumarate And Isoniazid In Bulk And Pharmaceutical Dosage …
2020
[8] Method Development and Validation for Simultaneous Estimation of Tenofovir Disoproxil Fumarate, Emtricitabine and Isoniazid In Bulk and Pharmaceutical Dosage …
2020
[9] DEVELOPMENT AND VALIDATION OF AN ANALYTICAL METHOD FOR DISSOLUTION TESTING OFEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE IN TABLET DOSAGE FORM BY UPLC
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY, 2019
[10] Emtricitabine
2019
[11] Simultaneous Estimation and Validation of Tenofovir Disoproxil Fumarate, Emtricitabine and Efavirenz by RP-HPLC Method in Combined Tablet Dosage Form
2019
[12] ANALYTICAL METHOD DEVELOPMENT FOR ASSAY DISSOLUTION AND RELATED COMPOUNDS OF CERTAIN ANTIRITROVIARL DRUGS IN …
2018
[13] Development and Validation of HPLC Method for Simultaneous Estimation of Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate Tablet Dosage form
2018
[14] Development and Validation of HPLC Method for Simultaneous Estimation of Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate Tablet Dosage …
2018
[15] ANALYTICAL METHOD DEVELOPMENT FOR ASSAY DISSOLUTION AND RELATED COMPOUNDS OF CERTAIN ANTIRITROVIARL DRUGS IN TABLET DOSAGE …
2018
[16] A STABILITY-INDICATING UPLC METHOD FOR SIMULTANEOUS QUANTIFICATION OF EMTRICITABINE, EFAVIRENZ AND TENOFOVIR DISOPROXIL FUMARATE IN BULK AND PHARMACEUTICAL DOSAGE FORMS
2017
[17] Validated gradient stability indicating rp-hplc method for the simultaneous quantification of 11 related substances in the combined dosage forms of lamivudine …
2017
[18] A STABILITY-INDICATING UPLC METHOD FOR SIMULTANEOUS QUANTIFICATION OF EMTRICITABINE, EFAVIRENZ AND TENOFOVIR DISOPROXIL …
2017
[19] Validated gradient stability indicating rp-hplc method for the simultaneous quantification of 11 related substances in the combined dosage forms of …
2017
[20] Stability-Indicating UPLC Method for Simultaneous Quantification of Emtricitabine, Efavirenz and Tenofovir Disoproxil Fumarate in pharmaceutical dosage forms
2015
[21] A Review On Development And Validation For Simultaneous Estimation And Stability Indicating Studies Of Emtricitabine, Rilpivirine, And Tenofovir Alafenamide …

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.